Restricted access

Review article

First published online February 14, 2023

Request permissions

Antimicrobial resistance in sexually transmitted Shigella in men who have sex with men: A systematic review

Holly O’Flanagan, Mohammed Siddiq, […], Carrie Llewellyn https://orcid.org/0000-0002-9107-8473, and Daniel Richardson https://orcid.org/0000-0003-0955-6307 [email protected]+1View all authors and affiliations

Volume 34, Issue 6

https://doi.org/10.1177/09564624231154942

Abstract
Data availability statement
References

Abstract

Background

Outbreaks of sexually transmitted Shigella flexneri and Shigella sonnei in men who have sex with men (MSM) are a major public health issue. While most cases can be managed conservatively, a minority require antimicrobial treatment. Recent reports have highlighted increasing antimicrobial resistant (AMR) strains of Shigella spp. in men who have sex with men. We aimed to systematically review antimicrobial resistance (and decreased antimicrobial sensitivity) in sexually transmitted shigella in men who have sex with men, focussing on macrolides, quinolones, and third generation cephalosporins.

Methods

We systematically searched 4 bibliographical databases (EMBASE, medline, EMCARE and CINAHL) from January 2011 to November 2021. We used a 2-stage process to assess eligibility: the primary author conducted an initial screen and then 3 authors conducted independent full-text reviews to determine the final eligible manuscripts. We only included manuscripts in English which included men who have sex with men with sexually transmitted shigella where data on antimicrobial resistance was available.

Results

Thirty-nine manuscripts met the inclusion criteria. A majority of the manuscripts (N = 34) described reduced susceptibility or antimicrobial resistant to macrolides, quinolones and third generation cephalosporins in circulating strains of shigella within sexual networks of men who have sex with men. Extensively drug resistant outbreaks of shigella in men who have sex with men have been reported containing genetic markers of ceftriaxone resistance (e.g. BlaCTX-M27) where isolates also contained markers of reduced susceptibility, and antimicrobial resistant to macrolides and quinolones.

Conclusion

There is little role for macrolides, quinolones or third generation cephalosporins in the management of sexually transmitted shigella in men who have sex with men. More research is needed to develop novel strategies for shigella control in men who have sex with men, as antimicrobial options are diminishing.

Get full access to this article

View all access and purchase options for this article.

Data availability statement

All the data from this work is in the manuscript.

References

1. Dritz SK, Ainsworth TE, Back A, et al. Patterns of sexually transmitted enteric diseases in a city. Lancet 1977; 2(8027): 3–4.

2. Cresswell FV, Ross S, Booth T, et al. Shigella flexneri: a cause of significant morbidity and associated with sexually transmitted infections in men who have sex with men. Sex Transm Dis 2015; 42(6): 344.

3. Schuster HJ, Gompelman M, Ang W, et al. An adult case with shigellosis-associated encephalopathy. BMJ Case Rep 2018; 2018: bcr2017222372.

4. Chen M, Delpech V, O’Sullivan B, et al. Shigella sonnei: another cause of sexually acquired reactive arthritis. Int J STD AIDS 2002; 13(2): 135–136.

5. Richardson D, Soni S. Are macrolides and quinolones the most appropriate antimicrobials for the presumptive treatment of sexually transmitted enteric infections? J Eur Acad Dermatol Venereol 2022; 36(7): e553–e554.

6. Locke RK, Greig DR, Jenkins C, et al. Acquisition and loss of CTX-M plasmids in Shigella species associated with MSM transmission in the UK. Microb Genom 2021; 7(8): 000644.

7. Ingle DJ, Andersson P, Valcanis M, et al. Prolonged outbreak of multidrug-resistant Shigella sonnei harboring bla (CTX-M-27) in Victoria, Australia. Antimicrob Agents Chemother 2020; 64(12): e01518–e01520.

8. Charles H, Prochazka M, Thorley K, et al. Outbreak of sexually transmitted, extensively drug-resistant Shigella sonnei in the UK, 2021-22: a descriptive epidemiological study. Lancet Infect Dis 2022; 22: 1503–1510.

9. de Vries HJC, Nori AV, Kiellberg Larsen H, et al. 2021 European guideline on the management of proctitis, proctocolitis and enteritis caused by sexually transmissible pathogens. J Eur Acad Dermatol Venereol 2021; 35(7): 1434–1443.

10. Centres for Disease Control and Prevention. Shigella: CDC. https://www.cdc.gov/shigella/index.html accessed january 2023.

11. Guidelines for the control of shigellosis, including epidemics due to Shigella dysenteriae type 1. Geneva, Switzerland: World Health Organization, 2005. pp. 1–70.

12. Heiman KE, Karlsson M, Grass J, et al. Notes from the field: Shigella with decreased susceptibility to azithromycin among men who have sex with men - United States, 2002-2013. MMWR Morb Mortal Wkly Rep 2014; 63(6): 132–133.

13. Toro C, Arroyo A, Sarria A, et al. Shigellosis in subjects with traveler’s diarrhea versus domestically acquired diarrhea: implications for antimicrobial therapy and human immunodeficiency virus surveillance. Am J Trop Med Hyg 2015; 93(3): 491–496.

14. Lane CR, Sutton B, Valcanis M, et al. Travel destinations and sexual behavior as indicators of antibiotic resistant Shigella Strains--Victoria, Australia. Clin Infect Dis 2016; 62(6): 722–729.

15. Gaudreau C, Ratnayake R, Pilon PA, et al. Ciprofloxacin-resistant Shigella sonnei among men who have sex with men, Canada, 2010. Emerg Infect Dis 2011; 17(9): 1747–1750.

16. Gaudreau C, Barkati S, Leduc JM, et al. Shigella spp. with reduced azithromycin susceptibility, Quebec, Canada, 2012-2013. Emerg Infect Dis 2014; 20(5): 854–856.

17. Gaudreau C, Pilon PA, Cornut G, et al. Shigella flexneri with ciprofloxacin resistance and reduced azithromycin susceptibility, Canada, 2015. Emerg Infect Dis 2016; 22(11): 2016–2018.

18. Hoffmann C, Sahly H, Jessen A, et al. High rates of quinolone-resistant strains of Shigella sonnei in HIV-infected MSM. Infection 2013; 41(5): 999–1003.

19. Bowen A, Eikmeier D, Talley P, et al. Notes from the field: outbreaks of Shigella sonnei Infection with decreased susceptibility to azithromycin among men who have sex with men - Chicago and metropolitan Minneapolis-St. Paul, 2014. Morb Mortal Wkly Rep 2015; 64(21): 597–598.

20. Hassing RJ, Melles DC, Goessens WH, et al. Case of Shigella flexneri infection with treatment failure due to azithromycin resistance in an HIV-positive patient. Infection 2014; 42(4): 789–790.

21. Eikmeier D, Talley P, Bowen A, et al. Decreased susceptibility to azithromycin in clinical Shigella isolates associated with HIV and sexually transmitted bacterial diseases, Minnesota, USA, 2012–2015. Emerg Infect Dis 2020; 26(4): 667–674.

22. Danila RN, Eikmeier DL, Robinson TJ, et al. Two concurrent enteric disease outbreaks among men who have sex with men, minneapolis-st Paul area. Clin Infect Dis 2014; 59(7): 987–989.

23. Murray K, Reddy V, Kornblum JS, et al. Increasing antibiotic resistance in Shigella spp. from infected New York City residents, New York, USA. Emerg Infect Dis 2017; 23(2): 332–335.

24. Valcanis M, Brown JD, Hazelton B, et al. Outbreak of locally acquired azithromycin-resistant Shigella flexneri infection in men who have sex with men. Pathology 2015; 47(1): 87–88.

25. Yousfi K, Gaudreau C, Pilon PA, et al. Genetic mechanisms behind the spread of reduced susceptibility to azithromycin in Shigella strains isolated from men who have sex with men in Québec, Canada. Antimicrob Agents Chemother 2019; 63(2): e01679–e01800.

26. Chiou CS, Izumiya H, Kawamura M, et al. The worldwide spread of ciprofloxacin-resistant Shigella sonnei among HIV-infected men who have sex with men, Taiwan. Clin Microbiol Infect 2016; 22(4): 383.e11–383.e16.

27. Huynh A, McGrath C, Johnson D, et al. Shigella sonnei bacteraemia occurring in a young man with Shigellosis. BMJ Case Rep 2015; 2015: bcr2014208875.

28. Serafino Wani RL, Filson SA, Chattaway MA, et al. Invasive shigellosis in MSM. Int J STD AIDS 2016; 27(10): 917–919.

29. Liao YS, Liu YY, Lo YC, et al. Azithromycin-nonsusceptible Shigella flexneri 3a in men who have sex with men, Taiwan, 2015-2016. Emerg Infect Dis 2016; 23(2): 345–346.

30. Wu HH, Shen YT, Chiou CS, et al. Shigellosis outbreak among MSM living with HIV: a case-control study in Taiwan, 2015-2016. Sex Transm Infect 2019; 95(1): 67–70.

31. Mook P, McCormick J, Bains M, et al. ESBL-producing and macrolide-resistant Shigella sonnei infections among men who have sex with men, England, 2015. Emerg Infect Dis 2016; 22(11): 1948–1952.

32. Mitchell HD, Mikhail AFW, Painset A, et al. Use of whole-genome sequencing to identify clusters of Shigella flexneri associated with sexual transmission in men who have sex with men in England: a validation study using linked behavioural data. Microb Genom 2019; 5(11): e000311.

33. Bardsley M, Jenkins C, Mitchell HD, et al. Persistent transmission of Shigellosis in England is associated with a recently emerged multidrug-resistant strain of Shigella sonnei. J Clin Microbiol 2020; 58(4): e01692–e01900.

34. Moreno-Mingorance A, Espinal P, Rodriguez V, et al. Circulation of multi-drug-resistant Shigella sonnei and Shigella flexneri among men who have sex with men in Barcelona, Spain, 2015–2019. Int J Antimicrob Agents 2021; 58(3): 106378.

35. Goulart MA, Wurcel AG. Shigellosis in men who have sex with men: an overlooked opportunity to counsel with pre-exposure prophylaxis for HIV. Int J STD AIDS 2016; 27(13): 1236–1238.

36. Richardson D, Devlin J, Fitzpatrick C, et al. Sexually transmitted Shigella flexneri and Shigella sonnei in men who have sex with men. Sex Transm Infect 2021; 97(3): 244.

37. Hinic V, Seth-Smith H, Stöckle M, et al. First report of sexually transmitted multi-drug resistant Shigella sonnei infections in Switzerland, investigated by whole genome sequencing. Swiss Med Wkly 2018; 148: w14645.

38. van den Beld MJC, Reubsaet FAG, Pijnacker R, et al. A multifactorial approach for surveillance of Shigella spp. and entero-invasive escherichia coli is important for detecting (inter)national clusters. Front Microbiol 2020; 11: 564103.

39. Ingle DJ, Easton M, Valcanis M, et al. Co-circulation of multidrug-resistant Shigella among men who have sex with men in Australia. Clin Infect Dis 2019; 69(9): 1535–1544.

40. Zatta M, Di Bella S, Busetti M, et al. Emergence of quinolone-resistant Shigella flexneri in Italy (March 2017). Int J STD AIDS 2018; 29(11): 1123–1126.

41. Newman KL, Newman GS, Cybulski RJ, et al. Gastroenteritis in men who have sex with men in Seattle, Washington, 2017-2018. Clin Infect Dis 2020; 71(1): 109–115.

42. Fischer N, Maex M, Mattheus W, et al. Genomic epidemiology of persistently circulating MDR Shigella sonnei strains associated with men who have sex with men (MSM) in Belgium (2013-19). J Antimicrob Chemother 2021; 77(1): 89–97.

43. Williamson D, Ingle D, Howden B. Extensively drug-resistant Shigellosis in Australia among men who have sex with men. N Engl J Med 2019; 381(25): 2477–2479.

44. Yeoh HL, Hall V, Williamson DA, et al. Locally acquired extended-spectrum β-lactamase Shigella infection. Med J Aust 2019; 211(4): 163–164.e1.

45. Worley JN, Javkar K, Hoffmann M, et al. Genomic drivers of multidrug-resistant Shigella affecting vulnerable patient populations in the United States and abroad. mBio 2021; 12(1): e03188–e03220.

46. Zayet S, Klopfenstein T, Pierron A, et al. Shigella sonnei, an emerging multidrug-resistant sexually transmitted pathogen in Franche-Comté, France. Emerg Microbes Infect 2021; 10(1): 1702–1705.

47. Dallman TJ, Charles H, Prochazka M, et al. Emergence of novel strains of Shigella flexneri associated with sexual transmission in adult men in England, 2019-2020. J Med Microbiol 2021; 70(10): 70.

48. Bowen A, Grass J, Bicknese A, et al. Elevated risk for antimicrobial drug-resistant Shigella infection among men who have sex with men, United States, 2011–2015. Emerg Infect Dis 2016; 22(9): 1613–1616.

49. Williamson DA, Chen MY. Emerging and reemerging sexually transmitted infections. N Engl J Med 2020; 382(21): 2023–2032.

50. Baker KS, Dallman TJ, Field N, et al. Horizontal antimicrobial resistance transfer drives epidemics of multiple Shigella species. Nat Commun 2018; 9(1): 1462.

51. Tobin-D’Angelo M, Oosmanally N, Wilson SN, et al. Shigella bacteremia, Georgia, USA, 2002–2012(1). Emerg Infect Dis 2020; 26(1): 122–124.

|

You currently have no access to this content. Visit the access options page to authenticate.